Organogenesis Holdings, Inc.
The biggest 3000 companies in the U.S. in the year of 2025.
Rating Overview
Rating Criteria
Rating Criteria Detail
Corporate Weaponization
Criteria:
Has canceled customers, suppliers, or vendors due to their political views or religious beliefs OR corporately boycotts, divests, or sanctions regions, people groups, or industries.
Risk Level:
LowerRationale:
Organogenesis has not publicly canceled customers, suppliers, or vendors based on political views or religious beliefs (1).
Criteria:
Charitable giving (including employee matching programs) policies or practices discriminate against charitable organizations based on views or religious beliefs.
Risk Level:
LowerRationale:
Organogenesis does not appear to discriminate against charitable organizations based on views or beliefs (1).
Criteria:
Employment policies fail to protect against viewpoint or other discrimination and/or are ideological in nature.
Risk Level:
HighRationale:
Organogenesis appears to prioritize diversity over merit in its leadership composition. From its Corporate Governance Guidelines: “In evaluating director candidates, the Board considers diversity of persons in terms of their expertise, age, gender, race, ethnicity, education, sexual orientation and other attributes” (1). The company does not provide viewpoint protections for its employees (2).
Corporate Governance and Public Policy
Criteria:
Uses corporate reputation to support causes, organizations, or policies hostile to freedom of expression.
Risk Level:
MediumRationale:
Organogenesis supports DEI within its business practices. From its 2024 Annual Report: “We believe that diversity and inclusion in the workplace enhance employee engagement and stimulate innovation, and that people in diverse groups work better, share information more broadly and consider a wider range of views” (1). Otherwise, it has not supported ideological causes or policies (2).
Criteria:
Uses corporate funds to advance ideological causes, organizations, or policies hostile to freedom of expression.
Risk Level:
LowerRationale:
Organogenesis has not used corporate funds to advance ideological causes, organizations, or policies (1).